Skip to main content
. 2015 Nov 9;61(Suppl 5):S493–S500. doi: 10.1093/cid/civ497

Table 1.

Estimated Incidence Rate Ratios (and 95% Confidence Intervals) for Prespecified Event Analyses

Event 2011 Campaign, Individual Level
2011 Campaign, Population Level
2010 Campaign, Population Level
CET SCCS SCRI CET SCCS SCRI CET SCCS SCRI
Abscess at injection site 1.0 (.1–16.0) 1.0 (.1–16.0)
Anaphylactic shock
Cellulitis
Convulsions 0.7 (.2–2.9) 1.3 (.6–2.9) 0.6 (.2–1.9) 2.2 (1.1–4.7) 1.7 (1.0–2.9) 0.5 (.2–1.0) 0.8 (.4–1.3) 1.4 (.7–2.8) 1.4 (.7–2.8)
Encephalomyelitis 1.0 (.1–16.0)
Fever 1.6 (1.3–1.9) 1.4 (1.2–1.6) 1.4 (1.2–1.7) 1.8 (1.6–2.1) 1.6 (1.4–1.8) 1.6 (1.4–1.8) 0.9 (.8–1.0) 1.3 (1.1–1.5) 1.3 (1.1–1.5)
Hypotonia
Laryngeal edema
Local reactions
Meningitis-like 0.5 (.0–5.5) 1.2 (.2–7.0) 1.5 (.3–9.0) 1.5 (.3–9.0)
Paralysis 0.6 (.1–2.8) 1.7 (.2–16.5) 1.9 (.5–7.9) 0.9 (.2–3.0) 1.5 (.4–5.3)
Purpura
Sepsis
Shock
Thrombosis
Unexplained death
Urticaria 3.3 (.4–156.6) 1.4 (.4–4.4) 1.3 (.3–4.7) 0.9 (.4–2.4) 1.0 (.5–2.2) 0.5 (.2–1.3) 1.5 (.7–3.3) 0.6 (.3–1.1) 0.6 (.3–1.1)
Wheezing 0.3 (.0–6.4) 0.6 (.2–2.4) 0.8 (.0–15.3) 0.5 (.0–5.5) 0.5 (.0–5.5)
Trauma (control) 0.9 (.6–1.4) 0.9 (.7–1.3) 1.0 (.7–1.5) 1.2 (.9–1.5) 1.0 (.8–1.2) 0.9 (.7–1.2) 0.6 (.4–.7) 0.8 (.6–1.0) 0.8 (.6–1.0)
Diarrhea (control) 0.7 (.5–1.1) 1.1 (.8–1.5) 1.0 (.7–1.6) 1.0 (.7–1.4) 1.1 (.8–1.4) 0.9 (.7–1.2) 1.3 (1.0–1.8) 1.4 (1.0–1.9) 1.4 (1.0–1.9)

Bold indicates P < .05.

Abbreviations: CET, conditional exact test; SCCS, self-controlled case series; SCRI, self-controlled risk interval.